The placebo responder rate in children and adolescents

Headache

Volumn 45, Issue 3, 2005, Pages 232-239

  Lewis, Donald W ^a   Winner, Paul ^b   Wasiewski, Warren ^c  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Adolescents; Children; Headache; Migraine

Indexed keywords

IBUPROFEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

AGE DISTRIBUTION; ANALGESIA; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIZZINESS; DRUG APPROVAL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; PATIENT EDUCATION; PEDIATRICS; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; XEROSTOMIA;

ACETAMINOPHEN; ACUTE DISEASE; ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CLINICAL TRIALS; HUMANS; MIGRAINE DISORDERS; PATIENT EDUCATION; PATIENT SELECTION; PLACEBOS; RESEARCH DESIGN; SEROTONIN AGONISTS;

EID: 15344339899     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05050.x     Document Type: Review

References (15)

1. Hamalainen ML, Hoppu K, Valkeila E et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48:102-107.
2. Lewis DW, Kellstein D, Burke B et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine headache Headache. 2002;42:780-786.
3. Ueberall M. Sumatriptan in paediatric and adolescent migraine. Cephalalgia. 2001;21(suppl 1):21-24.
4. Ueberall MA. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999;52:1507-1510.
5. Winner P, Rothner AD, Saper J et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000;106:989-997.
6. Ahonen K, Hamalainen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in the treatment of migraine attacks in children Neurology. 2004;62:883-887.
7. Winner P, Prensky A, Linder S et al. Adolescent migraine: efficacy and safety of sumatriptan tablets. J Neural Sci. 1997;150(suppl):S17-S22.
8. Hamalainen M. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently that adults? Neurology. 1997;48:1100-1103.
9. Winner P, Lewis D, Visser WH et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind placebo-controlled study. Headache. 2002;42:49-55.
10. Linder SL, Dowson AJ. Zolmitriptan provides effective migraine relief in adolescents. Int J Clin Pract. 2000;54:466-469.
11. Rothner AD, Edwards K, Kerr L et al. Efficacy and safety of naratriptan tablets in adolescent migraine. J Neural Sci. 1997;150(suppl 1):S106.
12. Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against central sensitization. Ann Neurol. 2004;55:27-36.
13. Burstein R, Collins B, Jakubowski. Defeating migraine pain with triptans: a race against development of cutaneous allodynia. Ann Neurol. 2004;55:19-26.
14. Mac Donald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache. 1994;34:581-582.
15. Linder SL, Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in the pediatric neurology office practice. Headache. 1996;36:419-422.